Two new edition's of Veterinary Focus, Royal Canin's free journal for companion animal veterinary surgeons are now available free of charge to UK vets.
Focus on Respiratory Disease includes features on brachycephalic syndrome, feline asthma, thoracic radiography of respiratory cases, canine fungal rhinitis, tracheobronchial foreign bodies in dogs and cats, emergency care of patients with acute respiratory distress, and respiratory parasitic diseases. Contributors include representatives from veterinary universities in Germany, Spain, Italy, the USA, and Argentina, and from the UK, Martin Sullivan BVMS, PhD, DVR, Dipl. ECVDI, MRCVS from Glasgow University and Mike Stafford Johnson, MVB, MRCVS, DVC Cert, SAM, MACVS from the Veterinary Cardiorespiratory Centre in Kenilworth.
Focus on Liver Disease includes features on feline inflammatory liver disease, canine portosystemic shunts, jaundice in the dog, extra-hepatic biliary system surgery, laboratory tests for liver disease, liver enzyme testing, diagnosis and treatment of liver tumours, and liver biopsy sampling. Contributors include representatives from veterinary universities in France, Spain, Italy, the USA, New Caledonia, Argentina, and Grenada, and from the Faculty of Veterinary Medicine, University of Edinburgh, Danielle Gunn-Moore, BSc. BVM&S, PhD, FHEA, MACVSc, MRCVS, Nicki Reed, BM&S, Cert VR.DSAM (Feline) Dipl. ECVIM-CA, MRCVS, and Kathryn Pratschke, MVB. MVM, Cert SAS, Dipl. ECVS, MRCVS.
Lee Danks, Royal Canin Veterinary Support manager, said: "Focus is a really interesting and informative publication, and with each issue focusing on a particular body system it offers a complete review of the latest thinking in each area. The contributors are all highly renowned in their individual fields, and being able to provide this kind of expertise to our veterinary partners is something we are really proud of."
Veterinary Focus is published in English, French, German, Chinese, Italian, Polish, Portuguese, Spanish, Japanese, Greek and Russian and reaches over 80,000 veterinary surgeons worldwide.
For a free copy of Focus, speak to your Royal Canin veterinary business manager, who will add you to the subscription list.
Veterinary practices are being urged to raise awareness of summer skin conditions, such as sweet itch, following research carried out by Elanco Companion Animal Health, distributor of Cavalesse, which revealed that vets only tend to be consulted after horse owners have tried to manage the condition themselves (73%), or if the clinical signs have become severe (67%), potentially leading to major welfare implications.
According to the research, this is despite the fact that over half (55%) of owners of a horse with sweet itch showed concern that their horse will suffer, and nearly half being stressed about the way the condition will affect it (47%). While many horse owners are fairly knowledgeable about the causes of sweet itch and its clinical signs, over a quarter of respondents (26%) did not start managing the condition before the midge season in the spring, which may make managing the condition more frustrating. Nearly a third (31%) stated that they had to curtail their activities with their horse due to welfare, aesthetic and behavioural issues, such as head shaking, rubbing, unpredictability and aggression.
Ed Whittle, technical consultant at Elanco Companion Animal Health said: "86% of those questioned considered sweet itch to be a very serious welfare issue if left untreated, with the worst aspects of the condition being the suffering and distress caused by the constant irritation which affects the quality of life of the horse. Over half (55%) felt that sweet itch had adversely affected the behaviour of their horse, making them difficult to handle or ride. Veterinary practices should be proactively talking to their clients about summer skin conditions such as sweet itch to help alleviate the suffering and distress caused by this frustrating disease."
Elanco says it will be joining forces with the British Horse Society (BHS), The Blue Cross, The Horse Trust, Redwings Horse Sanctuary and World Horse Welfare (WHW) to raise awareness of summer skin conditions, such as sweet itch, during Sweet Itch Awareness Month (SIAM) in March. The campaign will highlight the preventative measures that should be carried out to help alleviate sweet itch and the importance of management of the condition before the start of the midge season in the spring.
Lee Hackett, head of welfare at the BHS, said: "The results of this survey show just how important raising awareness of sweet itch is. All of us, whether we are welfare organisations or vets, need to play our part in educating owners about sweet itch in the hope that they will seek expert advice at an earlier stage and reduce the number of horses that suffer as a result of this condition."
Kerry Taylor, education officer at The Blue Cross, said: "The Blue Cross is pleased to be supporting the sweet itch campaign to raise awareness of the physical and mental impact this condition has on horses. During our May 2011 National Equine Health Survey, skin problems came out the top syndrome affecting horses, and we continue to see many horses coming into our care suffering from sweet itch. Prevention and early treatment is key to managing the potentially debilitating condition."
For further information on sweet itch, Sweet Itch Awareness Month or Cavalesse, please visit http://www.fidavet.com/, or contact Elanco Companion Animal Health, Lilly House, Priestley Road, Basingstoke, RG24 9NL, 01256 353131.
Reference
Sweet itch - effect on horse and owner. Mo Gannon & Associates. Web survey in November 2011. 351 responses - owners who have owned horses with sweet itch in the last two years.
Bayer Animal Health, maker of Advocate and organiser of the Be Lungworm Aware campaign, is warning that last year's damp summer and the mild winter conditions may lead to a continued spread of Angiostongylus vasorum in the UK.
Biodiversity & Conservation Officer for The Natural History Museum, Professor Fred Naggs, said: "An increase in the number of slug and snail populations this year would suggest there will consequently be a continued spread of the parasite. However, this depends on a number of factors: (i) the number of slugs and snails around last year, of which there were many (ii) the level of precipitation throughout the year, as slugs and snails will breed continuously when temperatures are mild to warm and there is adequate relative humidity. According to many reports in the press, last year was one of the wettest on record (iii) the survival of slugs and snails over the winter. As this winter has not been particularly harsh, reasonable numbers of slugs and snails should have survived."
In addition, a study by the RVC as shown that A. vasorum is spreading beyond the traditional geographic distribution with 20 per cent of veterinary practices across the country reporting at least one case of A. vasorum. 1
To help raise awareness of the parasite, veterinary surgeons and nurses are being encouraged to support the 'Be Lungworm Aware' campaign. The scheme will offer support and education to owners and participating vet practices throughout this month, which has been labelled 'Lungworm Awareness Month'.
Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "While dog owners are becoming more aware of A. vasorum, there is still a real lack of understanding as to the warning signs associated with the condition and how to prevent or treat it. Some owners still believe that Lungworm can be prevented by using normal intestinal wormers which is not the case - Advocate is the only product that can prevent A. vasorum, and from the first application. Our aim with the 'Be Lungworm Aware' campaign is to drive pet owners to their vet practice, where they can then be informed of the danger of the parasite and educated about correct preventative treatment."
Practices can request a range of materials including a practice press pack by calling their Bayer Territory Manager. The pack is designed to promote the awareness campaign to local dog owning clients and includes a regional press release, images and other collateral including leaflets, posters and a campaign DVD for display in waiting rooms.
For more information on lungworm, visit www.lungworm.co.uk
1. Royal Veterinary College survey 2012, 1,419 veterinary practices
The talk, by Stephanie Sorrell, Director of The Mindful Vet, will provide insights and tips on how to support staff, promote wellbeing and reduce the stigma associated with mental health in the workplace.
Hillary Noyes, Hill’s Veterinary Affairs Manager, UK & Republic of Ireland said: “Following an unprecedented two years the veterinary profession is still hugely affected by the pandemic with long working hours and limited staff leading to burnout and increased stress for many. “We hope this webinar will raise awareness of this prevalent issue, highlight the importance of burnout awareness and produce valuable insights into recognising the early signs, so that practices are equipped to tackle the crisis.”
To register for the webinar, visit: https://veterinarywebinars.com/register/hills/prevent-and-manage-burnout/
For the randomised controlled trial, 528 dairy heifers were monitored for 34 months to investigate the effects of routine treatment with a NSAID at calving and during treatment for lameness, on the future probability of lameness and culling.
The cows were exposed to normal farm conditions and were split into four groups:
During the study, the probability of lameness was assessed by a lameness outcome score collected every 14 days.
Data on culling was also extracted from farm records.
438 animals were included in the final analysis which revealed that treating a cohort of cows following the group three protocol led to an absolute reduction in lameness of approximately 10% and severe lameness of 3%, compared with animals treated in accordance with conventional best practice (group one).
James Wilson BSc(Hons) PhD, foot health consultant and lead researcher on the trial, said: “It appears that through giving heifers a NSAID at critical time points, we have imparted a substantial, long-lasting benefit to them.
"When freshly calved heifers enter the herd for the first time, we understand that they are (typically) naïve to lameness and have good hoof health.
"By utilising NSAIDs strategically, we believe that we have preserved the functionality of the foot, thereby reducing the risk of lameness.
"This is a highly efficacious, cost-effective means of managing lameness on farm.”
Herd Health Consultancy says that in dairy cows, it is advisable to consider using a zero milk-withhold NSAID which is fully licensed to treat lameness in cattle to avoid any need to discard milk, however no NSAID is currently licensed in the UK to treat the pain associated with calving, so careful advice should be given to farmers based on the farm type and production methods.
https://doi.org/10.3168/jds.2021-21329
Intervet / Schering Plough Animal Health has launched Leventa, an easily administered once daily, liquid treatment for canine hypothyroidism.
Leventa is a low volume liquid formulation of levothyroxine sodium which provides the thyroxine needed by dogs with hypothyroidism. The company says it is readily accepted.
Until now, thyroxine has only been available in a tablet format. Leventa comes in a single presentation 30 ml bottle with a dosing syringe suitable for all weights of dogs, allowing straightforward storage and stock control.
Leventa enables accurate dosing and easy dose titration. The ready-to-dispense pack avoids time-consuming tablet dispensing and handling of medications.
In addition to the practical compliance benefits of the liquid format, Intervet / Schering Plough says Leventa also offers excellent bio-availability1. In trials, 79% of dogs stabilised on the once daily starting dose of 20g/kg avoiding lengthy stabilisation2.
Vicki Winslet, Veterinary Advisor at Intervet / Schering Plough said: "One of the greatest challenges faced by vets for effective treatment is owner compliance. Leventa overcomes this issue with a simple syringe dose replacing the need for tablets of varying sizes and quantities."
One of the most common endocrine disorders in dogs but difficult to diagnose, hypothyroidism can lead to a variety of issues including weight gain, lethargy and coat problems (including dullness, loss or thinning). It can also cause insulin resistance in diabetic dogs.
The launch of Leventa further extends Intervet / Schering Plough's endocrine portfolio which includes Caninsulin, developed for the treatment of diabetes in small animals and Vidalta, a once daily treatment for hyperthyroidism in cats which is already proving extremely popular with the profession.
For further information, please contact your Intervet/Schering-Plough account manager or telephone the company's Veterinary Support Group on 01908 685685.
1. Le Traon G, Burgaud S, Horspool LJ. (2008) Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium. J Vet Pharmacol Ther 31:95-101.2. Gommeren K, Benchekroun G, Brennan S.F, Burgaud S, Daminet S, Horspool L.J.I, Le Traon G, Rosenberg D, Mooney C.T (2008) A novel L-thyroxine solution is a safe and effective once daily treatment for canine hypothyroidism. In:Proceedings BSAVA congress 2008 , 3-6 April Birmingham, UK pp487-488
The Office of Fair Trading has concluded that it has no grounds to take action against IDEXX Laboratories Limited following an investigation into alleged abuses of a dominant position in the veterinary diagnostic testing sector.
The OFT opened its investigation in November 2010 after it received a complaint alleging that IDEXX was abusing a dominant position in the market for the supply of in-clinic pet testing equipment in order to foreclose competition.
The conduct assessed by the OFT included alleged practices of:
The full reasoning for the OFT's conclusion, including details of the methodologies used by the OFT to assess potential theories of harm relating to alleged mixed bundling (also known as multi-product rebates) and alleged predatory pricing in systems markets, is available from the OFT's website, here.
Vétoquinol has announced plans to raise £10,000 for The Blue Cross pet charity through sales of Propalin, its fast acting treatment for incontinence in dogs.
From 1st July to 31st December this year, for every 100ml bottle of Propalin ordered, Vétoquinol will give 18p to The Blue Cross and 7p for every 30ml bottle.
To boost the amount raised for The Blue Cross, Vétoquinol is offering vets a free bottle of Propalin for every six bottles ordered of both the 100ml and 30ml sizes.
For example, if you order 18 100ml bottles of Propalin, you will receive 6 free bottles and The Blue Cross will receive £4.32.
Vanessa Rossiter, corporate fundraising officer for The Blue Cross said: “As a charity, The Blue Cross relies on donations to support our adoption centres and animal hospitals around the country. We are very grateful to Vétoquinol for their pledge to raise funds for the hundreds of needy animals in our care.”
According to Vétoquinol, Propalin is the UK’s best selling licensed veterinary treatment for urinary incontinence in the ***. It contains phenylpropanolamine hydrochloride, which acts to increase the tone in muscles that make up the urethal sphincter. It takes effect within 30 minutes of administration and, as a liquid, is highly palatable.
A collaborative team of researchers from the Waltham Centre for Pet Nutrition has shown that adding moisture to a cat's diet leads to an increase in activity and may help slow down weight gain.
In a series of studies conducted in partnership with the University of Aberdeen, Waltham scientists found that cats fed a dry diet with added water were more physically active and gained less weight than those cats fed the dry diet alone. According to the Centre, this is the first time reduced energy density diets have been associated with an increase in physical activity levels in cats.
Waltham scientist and author of the study, Dr. Penelope Morris, said: "These findings advance our understanding of the factors that influence body weight in cats and provide a strong basis for further research.
"Obesity is a growing problem in the cat population, recent figures indicate that up to 50 per cent of cats are either overweight or obese. These findings could have important implications for developing tailored diets that meet cats' energy and nutritional needs."
The research is part of a wider programme of ongoing collaborative research into the effect of food and nutrition on body weight in both cats and dogs.
The research has been published in the June edition (Volume 95, Issue 3) of the Journal of Animal Physiology and Animal Nutrition and is available in print and online: http://onlinelibrary.wiley.com/doi/10.1111/j.1439-0396.2010.01107.x/abstract
Companion Care Vets has announced it will work in partnership with VetAbroad, an e-learning company that has been established to help vets who qualified outside the UK to develop a successful career within it.
Companion Care is the first veterinary group in the UK to enter into partnership with VetAbroad, with the aim that all new non-UK employees will complete the course.
According to the company, almost 30% of vets registered in the UK are from overseas and statistics show that one in three will leave the register in less than 24 months and 20% in less than 12 months. Statistics also highlight the likelihood of a non-UK vet to be struck off or suspended is six times higher than for a UK vet.
Jane Balmain, Managing Director of Companion Care Vets said: "Whilst we as a company offer as much support as possible to our team members from overseas and support their continued learning , we are delighted to be working in partnership with VetAbroad to utilise their training solutions and further enhance what we offer to team members who come from overseas. All new employees will be required to take the course and we will also be encouraging our current overseas vets to complete it."
The e-course covers social and professional adaptation, compliance with current legislation, teamwork, productivity, client care and communication skills and VetAbroad states that those taking the course will substantially increase their chances of retaining and obtaining a job in the UK.
Vet and founder of VetAbroad Luis Sainz-Pardos said: "The primary aim of our course is to help vets who have qualified overseas to swiftly integrate into the UK system. Vets who have taken the course will be aware of UK legislation and should be able to interact with colleagues, clients and patients to a UK standard. As a result, the problems often associated with employing non-UK vets to work in UK practices are greatly reduced. I am thrilled to be working in partnership with Companion Care Vets, a company that I believe is thriving due to its investment in its most important asset - people."
For further information about VetAbroad please visit www.vetabroad.com
Following supply issues over the past 12 months, the company has gained regulatory approval to begin supplying Aqupharm through a new manufacturer.
Will Peel, marketing manager at Animalcare said: "We are aware of the challenges vets have faced over the past 12 months due to the shortage in supply, so we have been working hard to manage stock availability, however we are pleased that we are now able to supply the product on demand.
"We’d like to thank all our customers and wholesalers for their support and patience over the past year."
All existing Aqupharm products are available to order except Aqupharm no.3 which has been discontinued due to low market demand.
For product advice, contact: technical@animalcare.co.uk.
For further information or for orders, contact your local Animalcare Territory Manager or email animalcare@animalcare.co.uk.
https://www.aqupharm.co.uk
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from a former Kent-based veterinary surgeon, Warwick Seymour-Hamilton.
Mr Seymour-Hamilton was originally removed from the Register in June 1994 for failing to maintain his equipment and facilities such that it evidenced a total disregard of basic hygiene and care for animals, thereby bringing the profession into disrepute.
The restoration hearing on Friday 18 March was Mr Seymour-Hamilton’s fourth application for restoration, with previous applications being submitted but refused in July 1995, June 2010 and January 2015. However, as the Committee made its decision on the merits of the case before it, those previous applications were not admitted as relevant to its decision.
Mr Seymour-Hamilton told the Committee that he currently works as a herbalist and naturopath for humans and wished to be restored to the Register so he could include animals in his research. He had completed a course in herbal and naturopathic medicine at the College of Naturopathic Medicine in Dublin in 2010, and told the Committee that he believed that being restored to the Register would lend credence to his endeavours to secure funding and other support. He stated that he did not intend to work again in a veterinary practice.
However, the Committee rejected his application on a number of grounds, including the impact on animal welfare should Mr Seymour-Hamilton be restored to the Register; the length of time he had been off the Register and the fact that he was therefore not up-to-date with contemporary veterinary practice and professional conduct; and that his efforts to keep up-to-date in terms of knowledge, skills and developments in practice were insufficient.
Judith Webb, chairing the Committee and speaking on its behalf, said: "The Committee is concerned about the length of time that has passed since he last practised and the paucity of the evidence he has provided to establish that, if permitted to return to practice, he would be able to attain the professional standards required of a modern veterinary practitioner, either as regards surgical capabilities/competence or as regards his knowledge of currently available veterinary medicines."
She added: "This Committee’s obligations and duties are to see that the interests of animal welfare are properly protected by ensuring that only those who are properly trained, knowledgeable and experienced are permitted to treat animals and that public confidence in the standards of the profession are maintained. The risks attendant on a restoration of this applicant to the Register are, in the judgement of this Committee, plain and obvious. Accordingly, this application is refused."
Animal health specialist Fort Dodge Animal Health has announced the appointment of David Bartram BVetMed MRCVS DipM MCIM CDipAF as Technical Services Manager for Large Animals. David rejoins Fort Dodge after eight years, having previously been a Business Unit Manager for its Cydectin business. David Bartram graduated from the Royal Veterinary College in London in 1988 and, after three years in large animal practice, moved into the pharmaceutical industry where he has worked for the last 16 years. His most recent role was at Lilly, where he worked in Finance in the human sector of its pharmaceutical business. David has post graduate qualifications in marketing and finance. He replaces Susan Corning who has moved to a new role with Fort Dodge in Italy.
A survey carried out by Intervet/Schering-Plough Animal Health to launch Plerion, a chewable, flavoured wormer for dogs, has shown that most UK dog owners turn to their vet rather than a pet shop for advice on worming.
Over 83% of owners who took part in the survey said they follow their vet's advice on worming whilst fewer than 8% would follow the advice of their local pet shop. 63% choose to buy wormers from their vet against 35% buying wormers from a pet shop or online pharmacy.
Survey participants understood the importance of carrying out a regular worming programme with almost 80% stating that a dog should be wormed every three to four months. However, some owners cited forgetfulness as a reason for not worming their pet regularly and expressed a need for a reminder from their local vet practice.
Almost 85% of those who took part in the survey believed that not all wormers provide the same level of protection and almost 75% said that vet recommendation is the reason they purchase a specific brand of wormer. 94% of owners are aware that worms can affect people as well as dogs.
The survey revealed that 1 in 5 owners experienced difficulty in administering a complete dose due to their dog spitting out part or the entire tablet.
Intervet/Schering Plough says that Plerion should help reduce compliance issues; its innovative and tasty soft chew formulation meaning that most dogs will take it right out of the hand.
Sarah-Jane Minter, marketing manager at Intervet/Schering-Plough said: "When developing Plerion we knew it was essential to launch a product that made life easier for dog owners by being easy, and even fun, to administer as this would increase the likelihood of owners sticking to a regular worming programme. We are delighted by the feedback we are receiving from owners who report their once fussy dogs are taking the flavoured, chewable Plerion tablets as though they were treats."
Plerion is available in two tablet sizes that provide a combination of Pyrantel, Praziquantel and Oxantel which, the company says, gives effective treatment for the major endoparasites in a single dose including tapeworm Echinococcus multilocularis, as required by the Pets Travel Scheme (PETS).
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The Royal College of Veterinary Surgeons has refused to release the McKelvey Report in full, despite Freedom of Information requests made by VetSurgeon.org and others.
According to the College, it had always been the intention of RCVS Officers that the full report, which considered the building works in the Lower Ground Floor of the RCVS offices in Belgravia House, and the implementation of a new database, would be published.
However, on the advice of solicitors (Penningtons), only the recommendations of the Report were published initially, in November.
This publication followed discussion of the full report (one sentence was redacted on legal advice) by RCVS Council on 3 November.
Freedom of Information requests for the full report were then received by the College, so further, external senior legal advice was sought.
This advice, from Counsel, confirmed the original view from solicitors that it would be inappropriate to publish the report in full because it includes personal data, which ought not to be made public, under the Data Protection Act.
The College claims the meat of the report is in the recommendations, which account for approximately 50% of the report, and which are being taken forward by Officers and RCVS Council, with plans to put an Audit and Risk Committee in place taking priority.
The recommendations of the report, which were adopted by Council, were published online on 11 November and are available to download from the 'Related documents' box, above right.
Three veterinary surgeons and an appointed RCVS Councillor have been awarded an OBE in the Queen's Birthday Honours.
Caroline Freedman, who has been appointed to Council from the University of Edinburgh since 2005, received a British Empire Medal for services to animal welfare in Edinburgh. Caroline will be officially retiring from Council at RCVS Day on Friday 11 July but will remain as a lay member of the Practice Standards Group - the coordinating body for the Practice Standards Scheme.
Three veterinary surgeons were also awarded OBEs in the Queen's Birthday Honours. Sarah Cleaveland, Professor of Comparative Epidemiology at the University of Glasgow, was honoured for her contribution to veterinary epidemiology. Robert Houston, former Chief Veterinary Officer for Northern Ireland, was recognised for services to veterinary science in the country and Professor Julie Fitzpatrick, the Scientific Director of the Moredun Research Institute and Chief Executive of the Moredun Foundation, was honoured for services to animal health and science.
RCVS President Colonel Neil Smith said: "I am delighted to see these very deserving people from the veterinary world receive their due recognition in this year's Birthday Honours.
"During her time on Council Caroline has provided a greatly valued lay perspective on the veterinary issues of the day and I am pleased that she will continue to give her valuable insight to the organisation through the Practice Standards Group.
"Professor Cleaveland is our guest speaker at this year's RCVS Day where she will be speaking about her vital work in tackling zoonotic diseases on an international basis, so I am delighted to see that her contribution to human and animal health is being recognised.
"In addition, Bert Houston and Professor Fitzpatrick have contributed a great deal to both the veterinary profession and animal welfare in UK, with the latter being a member of our former Research Subcommittee."
A new study1 lead by led by Dr Séverine Tasker at the University of Bristol's School of Veterinary Sciences and published in the journal Clinical and Vaccine Immunology (CVI), has shown that cats previously infected with the blood-borne bacteria M. haemofelis develop immunity from re-infection.
Haemoplasmas are a group of blood borne bacteria found in a wide range of mammals, including domestic and wild cats, and can cause severe anaemia. The findings of the new study have significantly advanced researchers' knowledge of immunity for these pathogens.
Information about the immune responses that occur in animals following haemoplasma infection is relatively unknown, largely due to the fact that researchers struggle to study these bacteria as they are unable to grow them in the laboratory. Antibiotics do not consistently clear infection and without correct treatment the anaemia can be fatal. Recently haemoplasma associated anaemia has been reported in a human too.
The aim of the study was to determine whether cats who had previously recovered from M. haemofelis infection were protected from re-infection. The researchers found that they were, representing a significant advancement in scientists' knowledge of immunity for haemoplasma infections.
The exact methods of protective immunity could not be clearly identified despite extensive investigations, but the study's results suggest that a vaccine, using a weakened form of the bacteria, may offer protection against haemoplasma infection.
Séverine said: "This is the first study to demonstrate protective immunity against M. haemofelis reinfection and it provides important information for a possible future haemoplasma vaccine.
"Our findings could help prevent the disease in cats and could also be of particular importance to farm animal species where haemoplasma infections can cause huge financial losses."
The study recommends future research should explore whether the bacterial animal infection could be transmitted to humans and how the immune system targets the pathogen.
The event aims to deliver the latest knowledge on parrot nutrition and welfare and provide an opportunity to collaborate on education and potential next steps for research.
The full programme is as follows:
Sarah Hormozi, Head of Science & Education at PFMA said: “We are hoping to make it a worthwhile event, where parrot experts, welfare groups and parrot food industry can share their knowledge and experience.
"Through discussions we will come up with collective decisions and steps forward to improve the health and welfare of parrots that are kept in captivity, especially from a diet and nutrition perspective."
For ticket prices and to register: https://www.pfma.org.uk/pfma-parrot-symposium-2022
The journal provides free access to critical summaries of the best available evidence, called Knowledge Summaries, to help practitioners make informed evidence-based decisions in practice.
The new website has several new features, such as author and reviewer hubs, which contain information to guide contributors through the process of writing or reviewing papers for the journal.
A new ‘answer me’ button allows potential authors to pick a clinical query they are interested in answering and email it straight to the Editor, streamlining the process.
The new site also includes a new submission system, Editorial Manager, which streamlines the editorial process, communications with authors and reviewers, and the management of articles.
Kit Sturgess, Editor-in-Chief of Veterinary Evidence, says: “I am really excited by the new website; its look and functionality will significantly improve rapid access to information and further boost the engagement of the veterinary team with EBVM.
"After an impressive year for Veterinary Evidence, we have also moved to a new submission system, Editorial Manager, aimed at making the experience of submitting and reviewing papers easier and more efficient.
"Through the new website and publishing platform, the journal can get better metrics of how well we are supporting our readers, authors, and reviewers so we can use evidence to drive Quality Improvement.”
veterinaryevidence.org
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
Nominees for the RCVS Council and its Veterinary Nurses Council have been announced, with 13 candidates for the former and four for the latter.
The nominations closed on 31 January, and the following are standing:
RCVS Council
* denotes current RCVS Council member
VN Council
* denotes current VN Council member
International Cat Care has announced the winners of four new ‘Easy to Give’ awards and three ‘Cat Friendly’ awards.
The Easy to Give award was created to reward pharmaceutical companies whose products are easy to administer to cats. Previous examples have included drugs in a highly palatable form, smaller tablets, longer lasting preparations or those with an easier mode of administration.
Easy to Give winners this year are Virbac's Prinovox (ectoparasiticide), Norbrook's Loxicom (NSAID), and Ceva's Vectra Felis (ectoparasticide) and Zodon (antibiotic).
These latest winners bring the total number of Easy to Give awards presented, since their inception in 2005, to 35.
International Cat Care CEO, Claire Bessant, said: ‘It is so important that cats receive treatments prescribed for them, whether it is for preventive care or to treat a problem. If a drug is too difficult to get into the cat, owners often fail to complete the course, leaving the cat inadequately treated – as we worry about antibiotic resistance, this is particularly important beyond the individual animal too. Struggling with a cat to medicate can put a tension into the owner/cat relationship at a time when owners feel they want to be more supportive rather than seen as something to fear. This year we asked those trying the products if the act of medication had a negative effect on their relationship with their cat, as many people find that in the struggle to medicate, often the cat becomes fearful or aggressive towards them which owners also find very distressing. This kind of innovation by pharmaceutical companies is essential to feline health.’
Easy to Give awards are confined to prescription only medicines (POMs) or methods of delivering POMs. International Cat Care also recognises other products which have made a difference to cat wellbeing and welfare, with its Cat Friendly Awards.
The Cat Friendly Awards go to the SoftE Smart Collar from MDC, the SureFeed Microchip Pet Feeder from SureFlap and the Cat Carrier Tree from Royal Canin.
For more details on the work of the charity go to www.icatcare.org.
Ridgeway Research Ltd has a surplus supply of short-dated Target IgG kits on special offer.
The kits are to test for passive transfer to foals via colostrum. Each kit contains 20 tests and normally costs £74. They have been reduced to £20 to clear. The use by date is end February 2010.
If you are interested, please email jo@ridgewayresearch.co.uk, or ring 01594 530809 for further information.
Boehringer Ingelheim Vetmedica has launched a competition to find 12 dogs that have responded well to treatment with Vetmedin, to feature in the company's forthcoming 2012 Better Dogs calendar.
Boehringer is particularly interested in hearing about dogs with funny or quirky stories, or ones that have made a dramatic heart-warming recovery. If the submission makes it to the short list of 12 they will be featured in Vetmedin's 2012 Better Dogs Calendar which will be available to veterinary practices later in the year. In addition, the vet with the best story will win a £250 Red Letter Days' voucher with the 11 runners up winning the new BSAVA Manual of Thoracic Imaging.
In return for pet owners agreeing to their dog's story being submitted, Boehringer will send each veterinary practice a complimentary pack of either Vetmedin 1.25mg x 50 tablets or Vetmedin 5.0mg x 50 tablets, depending on the normal prescription, to give to their client.
Entries can be made either on the 2012 Better Dogs Calendar form which can be found in a recent Vetmedin mailing or via email to vetmedin.bra@boehringer-ingelheim.com. All entries should be accompanied by a photograph. Terms and conditions apply and the closing date for submissions is 30 September 2011.
For further information, please contact your Boehringer Ingelheim Vetmedica Territory Manager or call 01344 746959.